Cardiogenic Shock Symposium - 2026

This symposium, open to all WellSpan team members, will primarily focus on cardiologists, nurses, advanced practice providers, and cardiovascular services professionals involved in the care of patients with cardiogenic shock. The event will explore the latest advancements in the pathophysiology, diagnosis, and management of cardiogenic shock, with a particular emphasis on pulmonary hypertension, ECMO, LVAD, mechanical circulatory support, and ICU management strategies. The symposium will provide a collaborative environment for multidisciplinary teams to engage in case reviews and participate in roundtable discussions.

1. Discuss early Mechanical Circulatory Support placement in Cardiogenic Shock
2. Describe early identification of Cardiogenic Shock
3. Review ICU patient management with Cardiogenic Shock

AMA PRA Category 1 Credits™ (6.00 hours), ABIM MOC Part 2 (6.00 hours), ABS CC (6.00 hours), ABTS CC (6.00 hours), Non-Physician Attendance (6.00 hours)

Saturday, April 11, 2026, 8:00 AM - 3:30 PM, Other, York, PA

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Live Activity activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, April 11, 2026